We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




New Rapid Method for Determining Virus Infectivity Could Revolutionize Response to Future Pandemics

By LabMedica International staff writers
Posted on 25 Jul 2024

On average, every four years a new virus emerges that poses a pandemic threat, in addition to numerous already known viruses that have the potential to jump across species. More...

Currently, there is no test that can quickly determine whether a virus in a sample is intact and potentially infectious, or damaged and non-infectious, without requiring weeks of cell culture. The traditional method for assessing viral infectivity involves the use of cultured cells, which not only takes days to yield results but also requires specialized personnel and specific cell lines that are not always available for every virus. Additionally, this method is limited to evaluating antivirals that do not harm the cells, complicating the discovery of new disinfectants that can interrupt the chain of viral transmission. Now, a new groundbreaking assay can screen viruses against virucidal antivirals in minutes, enabling quick determination of the effectiveness of antiviral measures, such as disinfectants.

This innovative technique, devised by researchers at the University of Birmingham’s School of Chemistry (Birmingham, UK), has been described in a study published in ACS Biomacromolecules. It employs a dye that can ordinarily penetrate viruses through pores in the capsid (protein shell) that surrounds its genetic material (DNA or RNA). When the dye binds to the viral DNA or RNA, it emits a fluorescent signal. The resulting assay, named FAIRY (Fluorescence Assay for vIRal IntegritY), quickly indicates whether a virus is intact and likely infectious, or damaged and non-infectious. The effectiveness of the FAIRY assay was tested on various viruses, including herpes simplex virus (HSV-2), respiratory syncytial virus (RSV), cytomegalovirus (CMV), Human Rhinovirus-8 (HRV-8), Human Coronavirus OC43 (OC43), chikungunya virus (CHIKV), Dengue virus 1 and 2, zika virus, and enterovirus 71 (EV71).

The FAIRY assay’s broad applicability was demonstrated across both enveloped and non-enveloped viruses, and DNA and RNA viruses. These viruses were subjected to treatments with a variety of chemicals known for their virucidal properties, such as hydrogen peroxide, ethanol, isopropanol, and other antivirals. The tests confirmed that the FAIRY assay is a promising tool for the rapid evaluation of virucides that disrupt viral capsids.

“This simple, low-cost, assay uses ready-made consumables, and can rapidly screen multiple disinfectants and viruses, in a single microplate assay, for their ability to neutralize viral infectivity,” said Dr. Samuel Jones from Birmingham’s School of Chemistry led the research team that developed the FAIRY assay. “It could have screened every disinfectant for antiviral activity during the SARS-CoV-2 pandemic and so deliver a more rapid response during the next pandemic.”

Related Links:
University of Birmingham’s School of Chemistry


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
Clinical Informatics Platform
CLARION™
Automated Clinical Chemistry Analyzer
Envoy 500+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A research team led by Prof. Hsing I-Ming (center), Professor of the Department of Chemical and Biological Engineering at HKUST, has developed TEMPO, a thermodynamically programmed one-pot CRISPR platform for rapid, point-of-care nucleic acid testing. Mr. Wu Xiaolong (third right) and Ms. Li Yanan (first left), PhD students from the Department of Chemical and Biological Engineering, are the co-first authors of this study. (Photo courtesy of HKUST)

Single-Tube CRISPR Test Detects Pathogens and Genetic Variants in 30 Minutes

Rapid, accurate detection of infectious agents and single-nucleotide variants remains difficult to deliver outside centralized laboratories. Although multi-step nucleic acid workflows are sensitive, they... Read more

Pathology

view channel
Image Credit: Adobe Stock

New Journal Addresses Evolving Needs in Clinical and Translational Pathology

Clinical pathology underpins diagnosis and therapy selection across oncology and other major diseases, but the field is rapidly evolving as new technologies reshape how disease is studied and classified.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.